Internal nasal valve stenosis
Conditions
Interventions
Group 1: Endurance athlete with stenosis of the internal nasal valve who are treated with radiofrequency therapy of the internal nasal valve using Vivaer™ radiofrequency probe (AerinMedical, Inc., Sun
Sponsors
Klinik für HNO und Kopf- und Halschirurgie St. Elisabeth Hospital Universitätsklinikum der Ruhr-Universität Bochum
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The study participant understands the study procedures and agrees to participate by signing the consent form. 2. The study participant is male or female, at least 18 years of age. 3. The study participant must be healthy and free of clinically significant diseases that interfere with the study or procedures or affect its safety. 4. The study participants engage in endurance sports on a regular basis. This is defined by performing an endurance sport discipline, such as jogging, cycling, swimming, rowing, cross-country skiing, or cross-trainer for at least 30 minutes and at least 2 times a week consistently for the past 3 months. 5. The study participants complain of nasal airway obstruction when engaging in endurance sports. 6. The study participants suffer from functionally relevant nasal valve stenosis.
Exclusion criteria
Exclusion criteria: 1. Study participants are excluded a) With a cardiac pacemaker. b) with a blood coagulation disorder. c) with chronic obstructive pulmonary disease (COPD). d) with bronchial asthma. e) with a cardio-vascular disease. f) with joint arthrosis. g) with immunosuppression after transplantation or HIV infection. h) with an oncological disease. i) with consumption of performance-enhancing drugs. j) with drug, alcohol and nicotine consumption. k) with endoscopically detectable polyposis, transverse septum and sinusitic complaints. l) without improvement of nasal breathing in the Cottle test. m) without improvement of nasal breathing in the Q-Tips test. 2. Women who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the NOSE questionnaire score and maximum nasal airflow rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the spiroergometric measurement parameters: maximal oxygen uptake (VO2 max), nasal maximal oxygen uptake (VO2 max), respiratory exchange ratio and maximal respiratory minute volume | — |
Countries
Germany
Contacts
Public ContactJonas Jae-Hyun Park
Klinik für HNO und Kopf- und Halschirurgie St-Josefs- Hospital Hagen
Outcome results
None listed